Meeting
2021 ASCO Annual Meeting
Adding carbon nanoparticles to dual-tracers for the sentinel node evaluation after neoadjuvant chemotherapy in patients with pretreatment node-positive breast cancers: The TT-SLNB trial.
Authors
Jie Chen
Department of Breast Surgery, West China Hospital, Sichuan University, Chengdu, China
Jie Chen , Jiqiao Yang , Tao He , Yunhao Wu , Xian Jiang , Zhoukai Fu , Qing Lv , Shan Lu , Xiaodong Wang , Hongjiang Li , Jing Wang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Local-Regional Therapy
Clinical Trial Registration Number
ChiCTR2000039814
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 566)
DOI
10.1200/JCO.2021.39.15_suppl.566
Abstract #
566
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Node marking techniques and targeted axillary dissection in patients with cN1 disease undergoing neoadjuvant chemotherapy: Analysis of initial 500 participants in the ATNEC trial.
First Author: Amit Goyal
Poster
2023 ASCO Annual Meeting
Phase II study on feasibility of sentinel lymph node biopsy for ycN0 patients treated with primary chemotherapy in cT1-3N1M0 breast cancer (SHARE study).
First Author: Rikiya Nakamura
Poster
2022 ASCO Annual Meeting
ATNEC: A multicenter, randomized trial investigating whether axillary treatment can be avoided in patients with T1-3N1M0 breast cancer with no residual cancer in the lymph glands after neoadjuvant chemotherapy.
First Author: Amit Goyal
Poster
2019 Breakthrough
Identification of sentinel lymph nodes using contrast-enhanced ultrasound in breast cancer patients who underwent neoadjuvant chemotherapy.
First Author: Xiufeng Wu